Variations in Inflammatory Biomarkers Following the Addition of Sitagliptin in Patients With Type 2 Diabetes Not Controlled With Metformin
Internal Medicine - Japan
doi 10.2169/internalmedicine.52.8175
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Japanese Society of Internal Medicine